13F-HR filed by Venrock Adviser, LLC
Venrock Adviser, LLC filed this 13F-HR for the quarter ended 2022-06-30, filed 2022-08-15, with 28 holding rows worth $554,068,000.
- Accession
- 0001104659-22-091231
- Filer
- CIK 1615982
- Filed
- 2022-08-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2022
A holdings report, 28 entries on the cover page, a total value of $554,068,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $554,068,000 with VALUE read as thousands by filing date, 13F file number 028-20281. A later restatement replaced it, so the quarter does not use it. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| TRICIDA INC | 89610F101 | COM | 7,132,079 | $69,039,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 4,563,962 | $63,713,000 | thousands by filing date | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 9,300,000 | $46,291,000 | thousands by filing date | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 2,270,072 | $43,109,000 | thousands by filing date | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 1,711,102 | $41,460,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 4,038,117 | $36,424,000 | thousands by filing date | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 3,185,573 | $31,792,000 | thousands by filing date | |
| Instil Bio, Inc. | 45783C101 | Common Stock | 5,997,657 | $27,709,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 865,116 | $23,324,000 | thousands by filing date | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 1,852,919 | $21,438,000 | thousands by filing date | |
| VISTAGEN THERAPEUTICS INC | 92840H202 | COM | 20,697,286 | $18,214,000 | thousands by filing date | |
| MARINUS PHARMACEUTICALS INC | 56854Q200 | COM NEW | 3,156,803 | $15,279,000 | thousands by filing date | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 1,173,518 | $14,458,000 | thousands by filing date | |
| INOZYME PHARMA INC | 45790W108 | COM | 2,709,987 | $12,927,000 | thousands by filing date | |
| AKOUOS INC | 00973J101 | COM | 2,667,119 | $12,509,000 | thousands by filing date | |
| LIANBIO ADR | 53000N108 | COM | 5,378,341 | $11,617,000 | thousands by filing date | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 590,408 | $9,228,000 | thousands by filing date | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 3,050,022 | $8,571,000 | thousands by filing date | |
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 489,618 | $8,563,000 | thousands by filing date | |
| ANNEXON INC | 03589W102 | COM | 1,928,477 | $7,270,000 | thousands by filing date | |
| SAVARA INC | 805111101 | COM | 4,117,530 | $6,259,000 | thousands by filing date | |
| LYRA THERAPEUTICS INC | 55234L105 | COM | 924,170 | $5,222,000 | thousands by filing date | |
| PROVENTION BIO INC | 74374N102 | COM | 1,118,653 | $4,475,000 | thousands by filing date | |
| ALTIMMUNE INC | 02155H200 | COM NEW | 369,306 | $4,321,000 | thousands by filing date | |
| ATYR PHARMA INC | 002120202 | COM NEW | 1,398,889 | $3,959,000 | thousands by filing date | |
| AFFIMED N V | N01045108 | COM | 1,428,571 | $3,957,000 | thousands by filing date | |
| RALLYBIO CORP | 75120L100 | COM | 268,532 | $2,027,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 30,000 | $913,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-22-091231 | this filing | 2022-08-15 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001104659-23-060779 | base | 2023-05-15 | acceptance time not in the bulk data set |